Anupam Kumar, PhD

Title(s)Postdoctoral Scholar, Neurological Surgery
SchoolSchool of Medicine
Address1450 Third Street
San Francisco CA 94158
Phone--
ORCID ORCID Icon0000-0002-6717-3411 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    All India Institutes of Medical Science (AIIMS), Delhi,IndiaPhDBrain tumour
    VIT University, Vellore, IndiaMSBiomedical Genetics

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Heparan Sulfate Synthesized by Ext1 Regulates Receptor Tyrosine Kinase Signaling and Promotes Resistance to EGFR Inhibitors in GBM. Mol Cancer Res. 2021 01; 19(1):150-161. Ohkawa Y, Wade A, Lindberg OR, Chen KY, Tran VM, Brown SJ, Kumar A, Kalita M, James CD, Phillips JJ. PMID: 33028660.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM. . 2019 09; 18(9):1565-1576. McKinney A, Lindberg OR, Engler JR, Chen KY, Kumar A, Gong H, Lu KV, Simonds EF, Cloughesy TF, Liau LM, Prados M, Bollen AW, Berger MS, Shieh JTC, James CD, Nicolaides TP, Yong WH, Lai A, Hegi ME, Weiss WA, Phillips JJ. PMID: 31270152.
      View in: PubMed   Mentions: 3  Translation:HumansAnimalsCells
    3. Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas. J Neurooncol. 2018 Aug; 139(1):23-31. Kumar A, Nayak S, Pathak P, Purkait S, Malgulawar PB, Sharma MC, Suri V, Mukhopadhyay A, Suri A, Sarkar C. PMID: 29931616.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    4. Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma. Sci Rep. 2018 05 16; 8(1):7673. Nayak S, Aich M, Kumar A, Sengupta S, Bajad P, Dhapola P, Paul D, Narta K, Purkrait S, Mehani B, Suri A, Chakraborty D, Mukhopadhyay A, Sarkar C. PMID: 29769662.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    5. Loss-of-Function Mutations in Calcitonin Receptor (CALCR) Identify Highly Aggressive Glioblastoma with Poor Outcome. Clin Cancer Res. 2018 03 15; 24(6):1448-1458. Pal J, Patil V, Kumar A, Kaur K, Sarkar C, Somasundaram K. PMID: 29263181.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    6. One pot synthesis of carbon dots decorated carboxymethyl cellulose- hydroxyapatite nanocomposite for drug delivery, tissue engineering and Fe3+ ion sensing. Carbohydr Polym. 2018 Feb 01; 181:710-718. Sarkar C, Chowdhuri AR, Kumar A, Laha D, Garai S, Chakraborty J, Sahu SK. PMID: 29254027.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    7. Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma. J Neurochem. 2017 12; 143(6):671-683. Ahmad F, Patrick S, Sheikh T, Sharma V, Pathak P, Malgulwar PB, Kumar A, Joshi SD, Sarkar C, Sen E. PMID: 28833137.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    8. Clinicopathological and molecular characteristics of pediatric meningiomas. Neuropathology. 2018 Feb; 38(1):22-33. Battu S, Kumar A, Pathak P, Purkait S, Dhawan L, Sharma MC, Suri A, Singh M, Sarkar C, Suri V. PMID: 28901666.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. BRAF gene alterations and enhanced mammalian target of rapamycin signaling in gangliogliomas. Neurol India. 2017 Sep-Oct; 65(5):1076-1082. Kakkar A, Majumdar A, Pathak P, Kumar A, Kumari K, Tripathi M, Sharma MC, Suri V, Tandon V, Chandra SP, Sarkar C. PMID: 28879901.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    10. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma. Brain Pathol. 2017 Sep; 27(5):580-589. Pathak P, Kumar A, Jha P, Purkait S, Faruq M, Suri A, Suri V, Sharma MC, Sarkar C. PMID: 27608415.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    11. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas. J Neurooncol. 2016 12; 130(3):423-430. Kaur K, Kakkar A, Kumar A, Purkait S, Mallick S, Suri V, Sharma MC, Julka PK, Gupta D, Suri A, Sarkar C. PMID: 27576698.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    12. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs). Epilepsy Res. 2016 11; 127:141-151. Kakkar A, Majumdar A, Kumar A, Tripathi M, Pathak P, Sharma MC, Suri V, Tandon V, Chandra SP, Sarkar C. PMID: 27599148.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. Prognostic Stratification of GBMs Using Combinatorial Assessment of IDH1 Mutation, MGMT Promoter Methylation, and TERT Mutation Status: Experience from a Tertiary Care Center in India. Transl Oncol. 2016 Aug; 9(4):371-6. Purkait S, Mallick S, Sharma V, Kumar A, Pathak P, Jha P, Biswas A, Julka PK, Gupta D, Suri A, Datt Upadhyay A, Suri V, Sharma MC, Sarkar C. PMID: 27567961.
      View in: PubMed   Mentions: 2  
    14. ATRX loss in glioneuronal tumors with neuropil-like islands indicates similarity to diffuse astrocytic tumors. J Neurooncol. 2016 10; 130(1):63-68. Kakkar A, Nambirajan A, Kaur K, Kumar A, Mallick S, Suri V, Sarkar C, Kale SS, Garg A, Sharma MC. PMID: 27469217.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. ATRX in Diffuse Gliomas With its Mosaic/Heterogeneous Expression in a Subset. Brain Pathol. 2017 03; 27(2):138-145. Purkait S, Miller CA, Kumar A, Sharma V, Pathak P, Jha P, Sharma MC, Suri V, Suri A, Sharma BS, Fulton RS, Kale SS, Dahiya S, Sarkar C. PMID: 26833422.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    16. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma. Cell Death Dis. 2016 05 05; 7:e2213. Ahmad F, Dixit D, Sharma V, Kumar A, Joshi SD, Sarkar C, Sen E. PMID: 27148686.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    17. Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas. Exp Mol Pathol. 2016 Apr; 100(2):312-20. Purkait S, Sharma V, Kumar A, Pathak P, Mallick S, Jha P, Sharma MC, Suri V, Julka PK, Suri A, Sharma BS, Sarkar C. PMID: 26892683.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    18. A simplified approach for molecular classification of glioblastomas (GBMs): experience from a tertiary care center in India. Brain Tumor Pathol. 2016 Jul; 33(3):183-90. Purkait S, Mallick S, Sharma V, Kumar A, Pathak P, Jha P, Biswas A, Julka PK, Gupta D, Suri A, Upadhyay AD, Suri V, Sharma MC, Sarkar C. PMID: 26865311.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors. Brain Tumor Pathol. 2016 Apr; 33(2):117-28. Sharma V, Purkait S, Takkar S, Malgulwar PB, Kumar A, Pathak P, Suri V, Sharma MC, Suri A, Kale SS, Kulshreshtha R, Sarkar C. PMID: 26746204.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    20. 1p/14q co-deletion: A determinant of recurrence in histologically benign meningiomas. Indian J Pathol Microbiol. 2015 Oct-Dec; 58(4):433-8. Kakkar A, Kumar A, Das A, Pathak P, Sharma MC, Singh M, Suri A, Sarkar C, Suri V. PMID: 26549062.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    21. Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach. Brain Pathol. 2016 05; 26(3):334-43. Kaur K, Kakkar A, Kumar A, Mallick S, Julka PK, Gupta D, Suri A, Suri V, Sharma MC, Sarkar C. PMID: 26222673.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    22. Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs. Int J Cancer. 2015 Nov 15; 137(10):2343-53. Jha P, Agrawal R, Pathak P, Kumar A, Purkait S, Mallik S, Suri V, Chand Sharma M, Gupta D, Suri A, Sharma BS, Julka PK, Kulshreshtha R, Sarkar C. PMID: 25994230.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    23. Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors. Indian J Med Paediatr Oncol. 2015 Apr-Jun; 36(2):99-104. Mallick S, Gandhi AK, Joshi NP, Kumar A, Puri T, Sharma DN, Haresh KP, Gupta S, Julka PK, Rath GK, Sarkar C. PMID: 26157286.
      View in: PubMed   Mentions: 7  
    24. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior. Neurol India. 2014 Jul-Aug; 62(4):376-82. Kumar S, Kakkar A, Suri V, Kumar A, Bhagat U, Sharma MC, Singh M, Suri A, Sarkar C. PMID: 25237942.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    25. Meningeal hemangiopericytomas: a clinicopathological study with emphasis on MGMT (O(6) -methylguanine-DNA methyltransferase) promoter methylation status. Neuropathology. 2014 Aug; 34(4):333-42. Kakkar A, Kumar A, Jha P, Goyal N, Mallick S, Sharma MC, Suri A, Singh M, Kale SS, Julka PK, Sarkar C, Suri V. PMID: 24521400.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    Anupam's Networks
    Concepts (160)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-866-g4098221c on PROFILES-PWEB02.

    Copyright © The Regents of the University of California